144 related articles for article (PubMed ID: 2158635)
1. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.
Howlett AC; Champion TM; Wilken GH; Mechoulam R
Neuropharmacology; 1990 Feb; 29(2):161-5. PubMed ID: 2158635
[TBL] [Abstract][Full Text] [Related]
2. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ
Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911
[TBL] [Abstract][Full Text] [Related]
3. A novel probe for the cannabinoid receptor.
Devane WA; Breuer A; Sheskin T; Järbe TU; Eisen MS; Mechoulam R
J Med Chem; 1992 May; 35(11):2065-9. PubMed ID: 1317925
[TBL] [Abstract][Full Text] [Related]
4. A novel electrophilic high affinity irreversible probe for the cannabinoid receptor.
Morse KL; Fournier DJ; Li X; Grzybowska J; Makriyannis A
Life Sci; 1995; 56(23-24):1957-62. PubMed ID: 7776819
[TBL] [Abstract][Full Text] [Related]
5. Determination and characterization of a cannabinoid receptor in rat brain.
Devane WA; Dysarz FA; Johnson MR; Melvin LS; Howlett AC
Mol Pharmacol; 1988 Nov; 34(5):605-13. PubMed ID: 2848184
[TBL] [Abstract][Full Text] [Related]
6. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
Kaminski NE; Abood ME; Kessler FK; Martin BR; Schatz AR
Mol Pharmacol; 1992 Nov; 42(5):736-42. PubMed ID: 1279376
[TBL] [Abstract][Full Text] [Related]
7. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses.
Bonhaus DW; Chang LK; Kwan J; Martin GR
J Pharmacol Exp Ther; 1998 Dec; 287(3):884-8. PubMed ID: 9864268
[TBL] [Abstract][Full Text] [Related]
8. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.
Thomas BF; Wei X; Martin BR
J Pharmacol Exp Ther; 1992 Dec; 263(3):1383-90. PubMed ID: 1335065
[TBL] [Abstract][Full Text] [Related]
9. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
10. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes.
Hillard CJ; Bloom AS; Houslay MD
Biochem Pharmacol; 1986 Aug; 35(16):2797-803. PubMed ID: 3017362
[TBL] [Abstract][Full Text] [Related]
11. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.
Little PJ; Compton DR; Mechoulam R; Martin BR
Pharmacol Biochem Behav; 1989 Mar; 32(3):661-6. PubMed ID: 2544901
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibition of delta8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding.
Yamamoto I; Kimura T; Kamei A; Yoshida H; Watanabe K; Ho IK; Yoshimura H
Biol Pharm Bull; 1998 Apr; 21(4):408-10. PubMed ID: 9586583
[TBL] [Abstract][Full Text] [Related]
13. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
[TBL] [Abstract][Full Text] [Related]
14. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase.
Bayewitch M; Rhee MH; Avidor-Reiss T; Breuer A; Mechoulam R; Vogel Z
J Biol Chem; 1996 Apr; 271(17):9902-5. PubMed ID: 8626625
[TBL] [Abstract][Full Text] [Related]
15. Effects of delta 1- and delta 6-tetrahydrocannabinol on the adenylate cyclase activity in ventricular tissue of the rat heart.
Li DM; Ng CK
Clin Exp Pharmacol Physiol; 1984; 11(1):81-5. PubMed ID: 6325054
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.
Martin BR; Compton DR; Prescott WR; Barrett RL; Razdan RK
Drug Alcohol Depend; 1995 Mar; 37(3):231-40. PubMed ID: 7796717
[TBL] [Abstract][Full Text] [Related]
18. Identification of cannabinoid receptors in cultures of rat cerebellar granule cells.
Pacheco MA; Ward SJ; Childers SR
Brain Res; 1993 Feb; 603(1):102-10. PubMed ID: 8384043
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
[TBL] [Abstract][Full Text] [Related]
20. Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies.
Howlett AC; Scott DK; Wilken GH
Biochem Pharmacol; 1989 Oct; 38(19):3297-304. PubMed ID: 2554920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]